Shots: The MHRA has provided authorization for an emergency supply of AZD1222, for the active immunization of individuals aged ≥18yrs. The approval recommends 2 doses administered with an interval of […]readmore
Tags : Emergency
Shots: Abbott has received the US FDA’s EUA for AdviseDx SARS-CoV-2 IgM lab-based serology test for use on the ARCHITECT and Alinity platforms Till now, Abbott has received EUA for […]readmore
Shots: Regeneron has submitted a request to the US FDA seeking EUA for its REGN-COV2 investigational Ab regimen to treat COVID-19. If EUA is granted, the US govt. has committed […]readmore
Shots: The approval is based on the positive outcomes of a clinical trial assessing Itolizumab for its safety and efficacy in preventing CRS in moderate to severe ARDS patients due […]readmore
Shots: The companies will utilize Celularity’s CYNK-001 as a potential novel therapy for the treatment and prevention of coronaviruses targeting mainly 2019-nCoV Sorento will utilize its existing “state-of-the-art” cGMP cell […]readmore